Comparison

Condfy vs ABRAMEPO

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Condfy

This application digitizes processes and allows users to interact with on-site technologies. It offers features like authorized user registration, door access, camera viewing, and guest invitations via QR code or virtual keys. Additional functionalities require project manager consultation.

Highlights
  • Authorized user registration with photos
  • Door and gate access control
  • Access history logs
  • Live camera viewing
  • QR code and virtual key guest invitations
  • Delivery and maintenance control
  • Common area scheduling
Features
Read full description

O aplicativo oferece recursos e ferramentas voltadas a digitalização dos processos, além de possibilitar a interação dos usuários com as tecnologias utilizadas no local. Funcionalidades do App: (Atenção: Essas funcionalidades precisam ser contratadas com o gestor do projeto) - Cadastramento de Autorizados com foto - Abertura de Portas e Portões - Histórico de Acesso - Visualização das câmeras - Convite autônomo via QR Code - Convite autônomo via Chave Virtual - Avisar portaria de um Convidado - Bilhetes para portaria - Entrada Assistida - Mural de Avisos - Controle de Entregas - Abertura de Pedidos - Agendamento de Áreas Comuns - Lista de festas - Upload e visualização Documentos - Segunda via de Boleto - Controle de Manutenções - Pesquisa avançada de autorizados (Atenção: Essas funcionalidades precisam ser contratadas com o gestor projeto)

About

ABRAMEPO

Features
Read full description

A ABRAMEPO foi fundada em 2017 quando um grupo de médicos com pós-graduações de várias regiões do Brasil que sentiam-se preteridos e perseguidos no exercício da sua profissão, resolveram criar uma associação com o objetivo de representar e defender os médicos pós- graduados. Desde então, vários avanços no âmbito jurídico e institucional foram conquistados. A associação está em franco crescimento seja no número de membros, seja na representatividade da classe no cenário nacional. Este aplicativo dispõe de diversas funcionalidades para seu usuários, dentre elas: acesso à carteirinha, agenda de eventos, notícias e acesso à Área Restrita.

Screenshots

Condfy4 screens
ABRAMEPO2 screens

Verdict

The call

The clearest difference is update cadence: Condfy at every 6 weeks against ABRAMEPO's every 5 months. ABRAMEPO's advantage is iOS requirement (11.0 vs 13.4). On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

Condfy ships an update every 6 weeks, ABRAMEPO every 5 months. The most recent releases landed on October 18, 2026 and October 1, 2026 respectively.

Scorecard2 real differences · 8 level
Condfy versus ABRAMEPO: the parameters behind the verdict, then further details
ParameterCondfyABRAMEPO
PriceFreeFree
Rating3.0 (8 ratings) — better—
Positive reviews38.5% of reviews—
Number of ratings8 — better—
Update frequencyEvery 6 weeks — betterEvery 5 months
AdsNoNo
In-app purchasesNoNo
MonetizationFree—
DevicesiPhone, iPodiPhone, iPad, iPod — better
Requires iOS13.411.0 — better
Further details — not scored
Size129 MB5 MB
Age rating4+4+
DeveloperConvicty SoftwareAplanex

In-app purchases

None

Condfy

No in-app purchases

None

ABRAMEPO

No in-app purchases

Questions

Is Condfy free?
Condfy is free to download, with no in-app purchases.
Is ABRAMEPO free?
ABRAMEPO is free to download, with no in-app purchases.
Do Condfy or ABRAMEPO have ads?
Neither Condfy nor ABRAMEPO shows ads.
Which is updated more often, Condfy or ABRAMEPO?
Condfy ships an update every 6 weeks, and ABRAMEPO every 5 months. Most recently, Condfy was updated on October 18, 2026 and ABRAMEPO on October 1, 2026.

Other comparisons